0B68 Rihn, Jeffrey - Thomas Jefferson University - Thomas Jefferson University
jar009

Jeffrey A. Rihn, MD

Contact Dr. Rihn

925 Chestnut Street
5th Floor
Philadelphia, PA 19107

(800) 321-9999

Most Recent Peer-reviewed Publications

  1. Radiographic variables that may predict clinical outcomes in cervical disc replacement surgery
  2. Cost-effectiveness, QALYs, and incremental cost-effectiveness ratios
  3. Disc Space Preparation in Transforaminal Lumbar Interbody Fusion: A Comparison of Minimally Invasive and Open Approaches
  4. Cervical laminectomy width and spinal cord drift are risk factors for postoperative C5 palsy
  5. Adjacent segment disease in the lumbar spine following different treatment interventions
  6. Neurologic injury because of trauma after Type II odontoid nonunion
  7. Epidemiology of Spinal Injuries in Sports
  8. In response
  9. Defining the value of spine care
  10. Preoperative dela 0B68 y of more than 1 hour increases the risk of surgical site infection
  11. What is the incidence of dysphagia after posterior cervical surgery?
  12. Comparison of open and minimally invasive techniques for posterior lumbar instrumentation and fusion after open anterior lumbar interbody fusion
  13. Change in angular alignment is associated with early dysphagia after anterior cervical diskectomy and fusion
  14. Epidural steroid injections are associated with less improvement in patients with lumbar spinal stenosis: A subgroup analysis of the spine patient outcomes research trial
  15. The influence of obesity on the outcome of treatment of lumbar disc herniation: Analysis of the Spine Patient Outcomes Research Trial (SPORT)
  16. Current concepts: Classification of thoracolumbar fractures
  17. Introduction
  18. Imaging in the setting of thoracolumbar trauma: The use of magnetic resonance imaging to diagnose injury to the posterior ligamentous complex
  19. Does obesity affect outcomes of treatment for lumbar stenosis and degenerative spondylolisthesis? Analysis of the Spine Patient Outcomes Research Trial (SPORT)
  20. A biologic without guidelines: The YODA project and the future of bone morphogenetic protein-2 research
0